期刊文献+

HIV患者联合检测HCMV DNA和CD4+T细胞计数的临床意义 被引量:1

Clinicl significance of joint detection of HCMV-DNA and CD4+T cell count in HIV-infected patients
原文传递
导出
摘要 目的:探讨HIV患者HCMV DNA与CD4+T细胞计数和机会性感染的相关性。方法:对262例HIV患者外周血联合检测HCMV DNA与CD4+T细胞计数,并对其病程作回顾分析。结果:262例HIV阳性患者中HCMV DNA阳性44例(占16.8%),其中HCMV DNA阳性组CD4百分含量为4.43±5.41%,CD4绝对计数为26.73±46.74个/μl明显低于阴性组(P<0.001),HCMV感染的患者发生各种机会性感染和肿瘤的机会明显高于HCMV阴性组,HIV和HCMV双重感染的患者CD4+T细胞绝对值小于200个/μl有43例(占97.7%)。结论:HIV和HCMV双重感染的患者处于AIDS发病阶段,HCMV DNA与CD4+T细胞数量和机会性感染有相关性。 Objective:To evaluate the correlation of HCMV DNA and the CD4^+T cell count and opportunistic infections in HIV-infected patients.Methods: 262 cases of HIV-infected patients were tested for HCMV DNA and the CD4^+T cell count in peripheral blood,and the course of disease was retrospectively analyzed.Results: HCMV DNA was positive in 44 of 262(16.8%) HIV-infected patients.The percentage of CD4^+T cell in HCMV-positive group was 4.43±5.41 %and CD4^+T cell absolute counts in HCMV-positive group were 26.73±46.74 cells/μl,which was significantly lower than the HCMV-negative group of HIV-infected patients(P0.001),but with higher incidences of opportunistic infections and tumors.HIV and HCMV double-infected patients with CD4^+T cell absolute value 200/μl were 43 cases(97.7%).Conclusion: HIV and HCMV double-infected patients are in the AIDS disease onset stage,and HCMV DNA are related with the quantities of CD4^+T cells and opportunistic infections.
出处 《中国卫生检验杂志》 CAS 2011年第10期2485-2486,2495,共3页 Chinese Journal of Health Laboratory Technology
关键词 HIV患者 HCMVDNA CD4绝对计数 机会性感染 HIV-infected patients HCMV DNA CD4^+T cell count Opportunistic infections
  • 相关文献

参考文献10

  • 1Robain M, Boufassa F, Hubert JB, et al. Cytomegalovirus seroconversion as a cofactor for progression to AIDS [ J ]. AIDS, 2001,15 (2) : 251 - 256.
  • 2Tamarit A, Albrola J, Mir A, et al. Human cytomegalovirus(HCMV) - specific CD4 + T lymphocyte response in AIDS patients with no disease following HAART[ J] ,J Med Virol,2004,29(4) :308 -314.
  • 3卢联合,赵红心,李鑫,张铭,张福杰,韩宁.艾滋病合并巨细胞病毒感染11例临床分析[J].中国医刊,2006,41(7):32-33. 被引量:12
  • 4Yoshida A, Hitomi S, Fukui T, et al. Diagnosis and monitoring of human cytomegalovirus diseases in patients with human immunodeficiency virus infection by use of a real -time PCR assay[ J]. Clin Infect Dis, 2001,33 (10) : 1756 - 1761.
  • 5Badri M, Ehrlich R, Wood R, et al. Initiating co - trimoxazole prophylaxis in HIV- infected Africa: an evaluation of the provisional WHO/ UNAIDS recommendations [ J ]. AIDS ,2001,15 (9) : 1143 - 1148.
  • 6郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 7董红梅,徐小虎,于晓军,许锦阶,吕俊耀.HIV感染人CD4^+T细胞生物学特性的实验研究[J].中国感染控制杂志,2006,5(1):6-8. 被引量:5
  • 8Tamarit A, Alberola J, Mira JV, et al. Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long - term non - progressors [ J ]. J Med V irol, 2004,74 ( 3 ) :382 - 389.
  • 9陈志强,梁良,李保军,苗香芬,赵宏儒,王春燕,张彩雪,储俊武,李国浩.艾滋病患者机会性感染与CD_4^+ T细胞计数的关联分析[J].河北医药,2009,31(19):2552-2553. 被引量:18
  • 10Lilleri D, Piceinini G, Baldanti F, et al. Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4 + T cell count in the absence of HCMV - specific C D4 + T cell response[ J ]. J Clin Viral, 2003,26 ( 1 ) :95 - 100.

二级参考文献39

  • 1王焕玲,邱志峰,盛瑞媛,赵岩,朱晓春,郝英英,范洪伟,吕玮,马小军,刘正印,李太生.巨细胞病毒病50例临床分析[J].中华内科杂志,2004,43(8):600-603. 被引量:21
  • 2康来仪,潘孝彰,杨文雄,潘启超,杨文琪,李关汉,仲伟鉴,潘希和,翁心华.XQ-9302中药制剂对艾滋病毒Ⅰ型作用及其实验研究[J].上海中医药大学学报,1999,13(1):48-51. 被引量:2
  • 3郜桂菊,张福杰,姚均,赵红心,卢联合,李鑫.HIV感染者/AIDS患者CD_4^+细胞计数与机会性感染对应关系的临床分析[J].中国艾滋病性病,2005,11(4):241-243. 被引量:87
  • 4US.Public Health Service(USPHS)and Infectious Disease Society of America(IDSA).2001 USPHA/IDSA guidelines for the prevention ofopportunistic infected with human Immunodcficiency virus.MMWR.2001.1-68.
  • 5Crowe SM,Carlin JB,Stewart KL,et al.Predictive value of CD lymphocyte numbers for the development of opportunistic infectionsand malignancies in HIV-infected persons.J Acquir Immune Defic Syndr,1991,4:770-776.
  • 6U. S. Public Health Service(USPHS) and Infectious Disease Society of America( IDSA). 2001 USPHA/IDSA guidelines for the prevention of opportunistic infected with human immunodeficiency virus [ J ].MMWR,2001,1 - 68.
  • 7Burman W, El-Sadr WE, Matts J, et al. Continued low rates of Mycobacterium avium complex and bacterial pneumonia despite withdrawal of azithromycin prophylaxis among patients with CD4^+ cell rebound[A]. Program and abstracts of the 9th Conference on Retroviruses and Opportunictic Infections [ C]. Seattle, Washington, February 24 -28,2002,631.
  • 8Yangco BG, Von Bargen JC, Moorman AC, et al. Can PCP prophylaxis be safely discontinued among clinically improving HIV patients[ C] ?[ Abstract I - 262 ]. 38th ICAAC, San Diego, CA, 1998.
  • 9Anglaret X, Chene G, Attia A, et al Early chemotherapy with trimethoprin-sulphamethoxazole for HIV-1 infected adults in Abidjan,Cote d' Ivoire: a randomised control trial[J ]. Lancet, 1999,353:1463-1468.
  • 10Wiktor SZ Morokro MS, Grant AD, et al. Efficacy of trimethoprin-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-linfected patients with tuberculosis in Adidjan, Cote d' Ivoire: a randomised control trial [J ]. Lancetl, 999,353:1469 - 1474.

共引文献106

同被引文献10

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部